Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD

Respiratory Medicine

Volumn 109, Issue 7, 2015, Pages 882-889

  Díaz, Alejandro A ^a   Pinto Plata, Victor ^a   Hernández, Camila ^b   Peña, Javier ^b   Ramos, Cristóbal ^c   Díaz, Juan C ^c   Klaassen, Julieta ^b   Patino, Cecilia M ^d   Saldías, Fernando ^b   Díaz, Orlando ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

LAA; COPD; CT; Emphysema; Six minute walk distance

Indexed keywords

BRONCHODILATING AGENT; CARBON MONOXIDE; CORTICOSTEROID; HEMOGLOBIN;

6 MINUTE WALK DISTANCE; ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; INSPIRATORY CAPACITY; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PREDICTION; PRIORITY JOURNAL; SECONDARY ANALYSIS; SEX DIFFERENCE; SMOKING; TOTAL LUNG CAPACITY; COMPLICATION; EXERCISE TOLERANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PULMONARY EMPHYSEMA; WALKING;

AGED; CARBON MONOXIDE; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED; WALKING;

EID: 84930959293     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.04.009     Document Type: Article

References (44)

1. C.G. Cote, C. Casanova, J.M. Marin, M.V. Lopez, V. Pinto-Plata, M.M. de Oca, L.J. Dordelly, H. Nekach, and B.R. Celli Validation and comparison of reference equations for the 6-min walk distance test Eur Respir J 31 3 2008 571 578
2. M.A. Spruit, M.I. Polkey, B. Celli, L.D. Edwards, M.L. Watkins, V. Pinto-Plata, J. Vestbo, P.M. Calverley, R. Tal-Singer, and A. Agusti Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease J Am Med Dir Assoc 13 3 2012 291 297
3. V.M. Pinto-Plata, C. Cote, H. Cabral, J. Taylor, and B.R. Celli The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Eur Respir J 23 1 2004 28 33
4. M.A. Spruit, M.L. Watkins, L.D. Edwards, J. Vestbo, P.M. Calverley, V. Pinto-Plata, B.R. Celli, R. Tal-Singer, and E.F. Wouters Evaluation of CLtIPSEsi: determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort Respir Med 104 6 2010 849 857
5. A.E. Holland, C.J. Hill, T. Rasekaba, A. Lee, M.T. Naughton, and C.F. McDonald Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease Archives Phys Med Rehabilitation 91 2 2010 221 225
6. M.I. Polkey, M.A. Spruit, L.D. Edwards, M.L. Watkins, V. Pinto-Plata, J. Vestbo, P.M. Calverley, R. Tal-Singer, A. Agusti, and P.S. Bakke Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization Am J Respir Crit Care Med 187 4 2013 382 386
7. C. Casanova, C.G. Cote, J.M. Marin, J.P. de Torres, A. Aguirre-Jaime, R. Mendez, L. Dordelly, and B.R. Celli The 6-min walking distance: long-term follow up in patients with COPD Eur Respir J 29 3 2007 535 540
8. B. Frisk, B. Espehaug, J.A. Hardie, L.I. Strand, R. Moe-Nilssen, T.M. Eagan, P.S. Bakke, and E. Thorsen Physical activity and longitudinal change in 6-min walk distance in COPD patients Respir Med 108 1 2014 86 94
9. M.A. Ramon, E. Gimeno-Santos, J. Ferrer, E. Balcells, E. Rodriguez, J. de Batlle, F.P. Gomez, J. Sauleda, A. Ferrer, and J.A. Barbera Hospital admissions and exercise capacity decline in patients with COPD Eur Respir J 43 4 2014 1018 1027
10. G.R. Washko, F.J. Martinez, E.A. Hoffman, S.H. Loring, R.S. Estepar, A.A. Diaz, F.C. Sciurba, E.K. Silverman, M.K. Han, and M. Decamp Physiological and computed tomographic predictors of outcome from lung volume reduction surgery Am J Respir Crit Care Med 181 5 2010 494 500
11. A.A. Diaz, B. Bartholmai, R. San Jose Estepar, J. Ross, S. Matsuoka, T. Yamashiro, H. Hatabu, J.J. Reilly, E.K. Silverman, and G.R. Washko Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD Respir Med 104 8 2010 1145 1151
12. J.M. Hughes, and N.B. Pride Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components Am J Respir Crit Care Med 186 2 2012 132 139
13. M. Kirby, A. Owrangi, S. Svenningsen, A. Wheatley, H.O. Coxson, N.A. Paterson, D.G. McCormack, and G. Parraga On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI Thorax 68 8 2013 752 759
14. V.H. Mak, J.R. Bugler, C.M. Roberts, and S.G. Spiro Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation Thorax 48 1 1993 33 38
15. M.A. Thomashow, D. Shimbo, M.A. Parikh, E.A. Hoffman, J. Vogel-Claussen, K. Hueper, J. Fu, C.Y. Liu, D.A. Bluemke, and C.E. Ventetuolo Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The multi-ethnic study of atherosclerosis chronic obstructive pulmonary disease study Am J Respir Crit Care Med 188 1 2013 60 68
16. M. Nishimura, H. Makita, K. Nagai, S. Konno, Y. Nasuhara, M. Hasegawa, K. Shimizu, T. Betsuyaku, Y.M. Ito, and S. Fuke Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease Am J Respir Crit Care Med 185 1 2012 44 52
17. J. Vestbo, S.S. Hurd, A.G. Agusti, P.W. Jones, C. Vogelmeier, A. Anzueto, P.J. Barnes, L.M. Fabbri, F.J. Martinez, and M. Nishimura Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 4 2013 347 365
18. A.A. Diaz, A. Morales, J.C. Diaz, C. Ramos, J. Klaassen, F. Saldias, C. Aravena, R. Diaz, C. Lisboa, and G.R. Washko CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD Respir Med 107 4 2013 570 579
19. A.E. Holland, M.A. Spruit, T. Troosters, M.A. Puhan, V. Pepin, D. Saey, M.C. McCormack, B.W. Carlin, F.C. Sciurba, and F. Pitta An official European respiratory society/American thoracic society technical standard: field walking tests in chronic respiratory disease Eur Respir J 44 6 2014 1428 1446
20. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P. van der Grinten, and P. Gustafsson Standardisation of spirometry Eur Respir J 26 2 2005 319 338
21. N. Macintyre, R.O. Crapo, G. Viegi, D.C. Johnson, C.P. van der Grinten, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, and P. Enright Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 4 2005 720 735
22. J. Wanger, J.L. Clausen, A. Coates, O.F. Pedersen, V. Brusasco, F. Burgos, R. Casaburi, R. Crapo, P. Enright, and C.P. van der Grinten Standardisation of the measurement of lung volumes Eur Respir J 26 3 2005 511 522
23. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1 1999 179 187
24. R.O. Crapo, and A.H. Morris Standardized single breath normal values for carbon monoxide diffusing capacity Am Rev Respir Dis 123 2 1981 185 189
25. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society Eur Respir J Suppl 16 1993 5 40
26. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova, R. Tal-Singer, B. Miller, D.A. Lomas, A. Agusti, and W. Macnee Susceptibility to exacerbation in chronic obstructive pulmonary disease N. Engl J Med 363 12 2010 1128 1138
27. K. Terada, S. Muro, S. Sato, T. Ohara, A. Haruna, S. Marumo, D. Kinose, E. Ogawa, Y. Hoshino, and A. Niimi Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation Thorax 63 11 2008 951 955
28. S. Bernard, P. LeBlanc, F. Whittom, G. Carrier, J. Jobin, R. Belleau, and F. Maltais Peripheral muscle weakness in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 158 2 1998 629 634
29. B. Nam, and R. D' Agostino Discrimination index, the area under the ROC curve 2002 Birkhauser Boston, MA
30. B. Burrows, J.E. Kasik, A.H. Niden, and W.R. Barclay Clinical usefulness of the single-breath pulmonucy diffusing capacity test Am Rev Respir Dis 84 1961 789 806
31. R.J. Knudson, W.T. Kaltenborn, D.E. Knudson, and B. Burrows The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit Am Rev Respir Dis 135 4 1987 805 811
32. J.E. Cotes, D.J. Chinn, P.H. Quanjer, J. Roca, and J.C. Yernault Standardization of the measurement of transfer factor (diffusing capacity) Eur Respir J 6 Suppl 16 1993 41 52
33. M.J. Tsai, C.J. Yang, J.J. Hwang, and M.S. Huang Adjusting diffusing capacity of the lung for carbon monoxide for haemoglobin level Eur Respir J 41 2 2013 489
34. M.A. Puhan, D. Chandra, Z. Mosenifar, A. Ries, B. Make, N.N. Hansel, R.A. Wise, and F. Sciurba The minimal important difference of exercise tests in severe COPD Eur Respir J 37 4 2011 784 790
35. M.A. Puhan, M.J. Mador, U. Held, R. Goldstein, G.H. Guyatt, and H.J. Schunemann Interpretation of treatment changes in 6-minute walk distance in patients with COPD Eur Respir J 32 3 2008 637 643
36. O.M. Mets, C.F. Buckens, P. Zanen, I. Isgum, B. van Ginneken, M. Prokop, H.A. Gietema, J.W. Lammers, R. Vliegenthart, and M. Oudkerk Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans JAMA 306 16 2011 1775 1781
37. O. Diaz, C. Villafranca, H. Ghezzo, G. Borzone, A. Leiva, J. Milic-Emil, and C. Lisboa Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest Eur Respir J 16 2 2000 269 275
38. R.S. Estepar, G.L. Kinney, J.L. Black-Shinn, R.P. Bowler, G.L. Kindlmann, J.C. Ross, R. Kikinis, M.K. Han, C.E. Come, and A.A. Diaz Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications Am J Respir Crit Care Med 188 2 2013 231 239
39. R.G. Barr, D.A. Bluemke, F.S. Ahmed, J.J. Carr, P.L. Enright, E.A. Hoffman, R. Jiang, S.M. Kawut, R.A. Kronmal, and J.A. Lima Percent emphysema, airflow obstruction, and impaired left ventricular filling N Engl J Med 362 3 2010 217 227
40. T.B. Grydeland, A. Dirksen, H.O. Coxson, T.M. Eagan, E. Thorsen, S.G. Pillai, S. Sharma, G.E. Eide, A. Gulsvik, and P.S. Bakke Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms Am J Respir Crit Care Med 181 4 2010 353 359
41. D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, B. Aguilaniu, B. Make, and H. Magnussen Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 6 2004 832 840
42. J.M. Seymour, K. Ward, P.S. Sidhu, Z. Puthucheary, J. Steier, C.J. Jolley, G. Rafferty, M.I. Polkey, and J. Moxham Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD Thorax 64 5 2009 418 423
43. F. Sciurba, G.J. Criner, S.M. Lee, Z. Mohsenifar, D. Shade, W. Slivka, and R.A. Wise National Emphysema treatment trial research G: six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length Am J Respir Crit Care Med 167 11 2003 1522 1527
44. E. Beekman, I. Mesters, E.J. Hendriks, M.P. Klaassen, R. Gosselink, O.C. van Schayck, and R.A. de Bie Course length of 30 metres versus 10 metres has a significant influence on six-minute walk distance in patients with COPD: an experimental crossover study J Physiotherapy 59 3 2013 169 176